The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...

Psilera, Inc. ("Psilera"), a biotechnology company developing groundbreaking therapies for hard-to-treat neurological ...

TAMPA, Fla. and NEW YORK and BERLIN, Feb. 20, 2025 /PRNewswire/ -- Psilera, Inc. ("Psilera"), a biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders and ...

A white paper action plan will be released by Psilera later this year. Psilera convenes FTD leaders to advance research and patient care. "This event started as a "what if…" idea that quickly ...

Psilera convenes FTD leaders to advance research and patient care. "This event started as a "what if…" idea that quickly grew to become a robust conversation between many passionate and ...

idea that quickly grew to become a robust conversation between many passionate and brilliant professionals all working towards a common goal," said Dr. Chris Witowski, CEO, Psilera. "The response ...

"This event started as a "what if…" idea that quickly grew to become a robust conversation between many passionate and brilliant professionals all working towards a common goal," said Dr. Chris ...